Cyberonics, Inc. Company Profile | CYBX Company Information

http://www.selfdeterminationohsu.org/2010/01/02/
Cyberonics, Inc. (NASDAQ: CYBX) pioneered the Vagu s Nerve Stimulation (VNS Therapy ) System. Foundeed in 1987 to design, develop and markert implantable medical devices for the treatmentr of epilepsy and other debilitating neurological Cyberonics has emerged as a leadef in theneuromodulation industry. The VNS Therapy Systemj uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve in the left side of the This therapy has proven effective in significantly reducingg thenumber and/or intensithy of seizures in many people suffering from epilepsyh and has the potential for use in the treatmenf of other inadequately chronic disorders.
In 1997, Cyberonics received approvaol from the Food and Drug Administration to market VNS Therapy for the treatmentof epilepsy. Since that more than 50,000 patients worldwide have been implanteed withthe device. These patients have accumulatedc in excessof 100,000 patient years of experienc using this life-enhancing therapy. The remarkable success of VNS Therapgy in the treatment of epilepsy has servefd as a platform forcontinuecd innovation. On July 15, 2005 , afted seven years of extensive study andclinical trials, VNS Therapt was approved by the FDA as a long-terk adjunctive treatment for treatment-resistant depression. ...